MEAGAN ALBERTS: Open Payments
NPI 1982046264 · WHEATON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$882 in 37 payments from 11 companies in 2025. Trend: 2023 $63 · 2024 $386 · 2025 $882
Food & beverage: $882
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $162 |
| Regeneron Healthcare Solutions, Inc. | 6 | $162 |
| Novartis Pharmaceuticals Corporation | 5 | $95 |
| UCB, Inc. | 3 | $91 |
| ABBVIE INC. | 4 | $88 |
| Janssen Biotech, Inc. | 3 | $78 |
| Lilly USA, LLC | 3 | $68 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $48 |
| Organon LLC | 2 | $43 |
| Amgen Inc. | 2 | $32 |
Products named: DUPIXENT, COSENTYX, Bimzelx, TREMFYA, TALTZ, RINVOQ, Winlevi, OTEZLA.
Industry payments across IL — which companies pay providers there.
